These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25881171)

  • 41. Potential epigenetic therapeutics for atherosclerosis treatment.
    Nicorescu I; Dallinga GM; de Winther MPJ; Stroes ESG; Bahjat M
    Atherosclerosis; 2019 Feb; 281():189-197. PubMed ID: 30340764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
    Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methyltransferase 1 and Krüppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis.
    Tang RZ; Zhu JJ; Yang FF; Zhang YP; Xie SA; Liu YF; Yao WJ; Pang W; Han LL; Kong W; Wang YX; Zhang T; Zhou J
    J Mol Cell Cardiol; 2019 Mar; 128():11-24. PubMed ID: 30659837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5.
    Fu DN; Wang Y; Yu LJ; Liu MJ; Zhen D
    Exp Cell Res; 2021 Apr; 401(2):112519. PubMed ID: 33636159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice.
    Jiang Y; Zhang H; Sun T; Wang J; Sun W; Gong H; Yang B; Shi Y; Wei J
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):866-75. PubMed ID: 23017835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE-/- mice.
    Fuijkschot WW; Morrison MC; van der Linden R; Krijnen PAJ; Zethof IPA; Theyse LFH; Kleemann R; Niessen HWM; Smulders YM
    Atherosclerosis; 2016 Dec; 255():164-170. PubMed ID: 27825629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrative DNA methylation and gene expression analyses identify DNA packaging and epigenetic regulatory genes associated with low motility sperm.
    Pacheco SE; Houseman EA; Christensen BC; Marsit CJ; Kelsey KT; Sigman M; Boekelheide K
    PLoS One; 2011; 6(6):e20280. PubMed ID: 21674046
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Toghill BJ; Saratzis A; Freeman PJ; Sylvius N; ; Bown MJ
    Clin Epigenetics; 2018; 10():29. PubMed ID: 29507647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.
    Centa M; Jin H; Hofste L; Hellberg S; Busch A; Baumgartner R; Verzaal NJ; Lind Enoksson S; Perisic Matic L; Boddul SV; Atzler D; Li DY; Sun C; Hansson GK; Ketelhuth DFJ; Hedin U; Wermeling F; Lutgens E; Binder CJ; Maegdesfessel L; Malin SG
    Circulation; 2019 May; 139(21):2466-2482. PubMed ID: 30894016
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Huaman MA; Qualls JE; Jose S; Schmidt SM; Moussa A; Kuhel DG; Konaniah E; Komaravolu RK; Fichtenbaum CJ; Deepe GS; Hui DY
    Front Immunol; 2020; 11():607957. PubMed ID: 33391278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.
    Hsu CC; Paik J; Brabb TL; O'Brien KD; Kim J; Sullivan BG; Hudkins KL; Seamons A; Finley JC; Meeker SM; Maggio-Price L
    Comp Med; 2015 Oct; 65(5):369-81. PubMed ID: 26473341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Any Cardiovascular Disease-Specific DNA Methylation Biomarker Within Reach?
    de la Rocha C; Zaina S; Lund G
    Curr Atheroscler Rep; 2020 Aug; 22(10):62. PubMed ID: 32844297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.
    Herías V; Biessen EA; Beckers C; Delsing D; Liao M; Daemen MJ; Pham CC; Heeneman S
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):79-86. PubMed ID: 25395616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
    Wan Q; Liu Z; Yang M; Wu J
    Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.